Man Group PLC Organon & Co. Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Organon & Co. stock. As of the latest transaction made, Man Group PLC holds 131,437 shares of OGN stock, worth $1.92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

131,437

Previous 116,704 12.62%

Holding current value

$1.92 Million

Previous $2.42 Million 4.1%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.65 - $23.03 $274,770 - $339,300	14,733 Added 12.62%	131,437 $2.51 Million
Q2 2024 Aug 14, 2024	BUY	$17.45 - $21.96 $1.47 Million - $1.85 Million	84,328 Added 260.46%	116,704 $2.42 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $30,646 - $41,811	2,224 Added 7.38%	32,376 $608,000
Q4 2023 Feb 14, 2024	SELL	$10.95 - $17.32 $275,929 - $436,446	-25,199 Reduced 45.53%	30,152 $434,000
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $5.76 Million - $8.26 Million	-347,372 Reduced 86.26%	55,351 $960,000
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $7.76 Million - $9.92 Million	402,723 New	402,723 $8.38 Million
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $2.61 Million - $3.21 Million	-82,416 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $1.42 Million - $1.84 Million	46,704 Added 130.78%	82,416 $2.88 Million
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $300,146 - $388,713	10,469 Added 41.47%	35,712 $1.09 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $298,324 - $371,368	10,420 Added 70.3%	25,243 $828,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $421,714 - $563,274	14,823 New	14,823 $448,000

Others Institutions Holding OGN

# of Institutions

793

Shares Held

192M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.71B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account